| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 5893198 | Current Opinion in Genetics & Development | 2016 | 8 Pages | 
Abstract
												Metabolic reprogramming in cancer supports the increased biosynthesis required for unchecked proliferation. Increased glucose utilization is a defining feature of many cancers that is accompanied by altered pyruvate partitioning and mitochondrial metabolism. Cancer cells also require mitochondrial tricarboxylic acid cycle activity and electron transport chain function for biosynthetic competency and proliferation. Recent evidence demonstrates that mitochondrial pyruvate carrier (MPC) function is abnormal in some cancers and that increasing MPC activity may decrease cancer proliferation. Here we examine recent findings on MPC function and cancer metabolism. Special emphasis is placed on the compartmentalization of pyruvate metabolism and the alternative routes of metabolism that maintain the cellular biosynthetic pools required for unrestrained proliferation in cancer.
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Developmental Biology
												
											Authors
												Adam J Rauckhorst, Eric B Taylor, 
											